| Symbol | Company | Owner | Relationship | Date | Transaction | Cost | # Shares | Value ($) | Total Shares | Filing | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| SYRS | Syros Pharmaceuticals, Inc. | Stephens Kristin | Chief Development Officer | Apr 01, 2024 | Option Exercise | $5.12 | 4,218 | 21,596 | 25,237 | Apr 02, 2024, 05:01 PM | |
| SYRS | Syros Pharmaceuticals, Inc. | Stephens Kristin | Chief Development Officer | Nov 01, 2023 | Option Exercise | $2.22 | 5,676 | 12,601 | 15,789 | Nov 02, 2023, 04:52 PM | |
| SYRS | Syros Pharmaceuticals, Inc. | Stephens Kristin | Chief Development Officer | Apr 03, 2023 | Option Exercise | $2.58 | 623 | 1,607 | 4,465 | Apr 04, 2023, 06:55 PM | |
| SYRS | Syros Pharmaceuticals, Inc. | Stephens Kristin | Chief Development Officer | Apr 01, 2022 | Option Exercise | $1.12 | 14,115 | 15,809 | 30,885 | Apr 04, 2022, 05:04 PM |
Menu